Technical Analysis for CNTG - Centogene N.V.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.39 | -13.33% | -0.06 |
CNTG closed down 13.33 percent on Wednesday, May 8, 2024, on 9.83 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 29
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -13.33% | |
| Shooting Star Candlestick | Bearish | -13.33% | |
| Lizard Bearish | Bearish Day Trade Setup | -13.33% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 15 hours ago |
| Fell Below Lower Bollinger Band | about 15 hours ago |
| Down 1 ATR | about 15 hours ago |
| Down 10% | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.98 |
| 52 Week Low | 0.39 |
| Average Volume | 99,164 |
| 200-Day Moving Average | 0.99 |
| 50-Day Moving Average | 0.60 |
| 20-Day Moving Average | 0.47 |
| 10-Day Moving Average | 0.45 |
| Average True Range | 0.06 |
| RSI (14) | 29.08 |
| ADX | 37.18 |
| +DI | 19.97 |
| -DI | 26.54 |
| Chandelier Exit (Long, 3 ATRs) | 0.52 |
| Chandelier Exit (Short, 3 ATRs) | 0.57 |
| Upper Bollinger Bands | 0.57 |
| Lower Bollinger Band | 0.37 |
| Percent B (%b) | 0.09 |
| BandWidth | 41.89 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.06 |
| MACD Histogram | 0.0042 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.46 | ||||
| Resistance 3 (R3) | 0.47 | 0.45 | 0.45 | ||
| Resistance 2 (R2) | 0.45 | 0.43 | 0.45 | 0.44 | |
| Resistance 1 (R1) | 0.42 | 0.42 | 0.41 | 0.41 | 0.44 |
| Pivot Point | 0.41 | 0.41 | 0.40 | 0.40 | 0.41 |
| Support 1 (S1) | 0.37 | 0.39 | 0.37 | 0.37 | 0.34 |
| Support 2 (S2) | 0.36 | 0.38 | 0.36 | 0.34 | |
| Support 3 (S3) | 0.33 | 0.36 | 0.33 | ||
| Support 4 (S4) | 0.32 |
